Cagrilintide Dosage Calculator
Calculate cagrilintide injection volumes. Pre-filled for a 2.4mg vial with 0.5ml BAC water (4,800 mcg/ml). Full dose = 0.5ml = 50 units.
Dose Reference Table
Pre-calculated for a 2.4mg vial + 0.5ml BAC water = 4,800 mcg/ml concentration. Using a 100-unit (1ml) insulin syringe.
| Dose | Inject Volume (ml) | Syringe Units |
|---|---|---|
| 300mcg | 0.063 ml | 6.3 units |
| 600mcg | 0.125 ml | 12.5 units |
| 1200mcg | 0.250 ml | 25 units |
| 2400mcg (2.4mg) | 0.500 ml | 50 units |
About Cagrilintide
Cagrilintide is a long-acting amylin analogue developed by Novo Nordisk. Amylin is a peptide hormone co-secreted with insulin from pancreatic beta cells in response to meals. It plays a role in satiety signaling, gastric emptying, and glucagon suppression. Cagrilintide is designed for once-weekly subcutaneous administration due to modifications that extend its half-life to approximately 7 days.
The most exciting research on cagrilintide involves its combination with semaglutide, known as "CagriSema." This combination showed remarkable weight loss results in clinical trials — potentially superior to either agent alone — by targeting both GLP-1 and amylin receptor pathways simultaneously.
Cagrilintide is typically supplied in 2.4mg vials, mirroring the maximum weekly dose studied in clinical trials. Reconstituting with 0.5ml of bacteriostatic water gives a concentration of 4,800 mcg/ml. The full 2.4mg dose requires 0.5ml = 50 units on a 100-unit insulin syringe.
As an investigational compound, cagrilintide is studied for its effects on body weight, glycemic control, and metabolic health, typically in combination with GLP-1 receptor agonists.